NASDAQ:THRN - Nasdaq - US8852601090 - Common Stock - Currency: USD
10.19
-0.01 (-0.1%)
The current stock price of THRN is 10.19 USD. In the past year, price increased by 121.52%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
UL | UNILEVER PLC-SPONSORED ADR | 23.29 | 138.82B | ||
HLN | HALEON PLC-ADR | 23.44 | 45.58B | ||
KVUE | KENVUE INC | 20.46 | 44.71B | ||
EL | ESTEE LAUDER COMPANIES-CL A | 30.3 | 25.83B | ||
BRBR | BELLRING BRANDS INC | 35.08 | 9.36B | ||
COTY | COTY INC-CL A | 20.39 | 4.98B | ||
IPAR | INTERPARFUMS INC | 28.81 | 4.30B | ||
ELF | ELF BEAUTY INC | 23.86 | 4.23B | ||
ODD | ODDITY TECH LTD-CL A | 22.92 | 2.51B | ||
EPC | EDGEWELL PERSONAL CARE CO | 10.64 | 1.50B | ||
OLPX | OLAPLEX HOLDINGS INC | 10.92 | 941.35M | ||
HLF | HERBALIFE LTD | 4.24 | 837.56M |
Thorne HealthTech, Inc. is engaged in the provision of a total system for wellness. The company is headquartered in Summerville, South Carolina and currently employs 544 full-time employees. The company went IPO on 2021-09-23. The Company’s vertically integrated brands, Thorne and Onegevity, provide actionable insights and personalized data, products and services that individuals to take a proactive approach to improve and maintain their health over their lifetime. By combining its multi-omics database, artificial intelligence (AI) and digital health content with its science-backed nutritional supplements, it delivers a total system for wellness. Thorne provides health tests, education, and products that support the optimization of health. Onegevity provides a comprehensive molecular portrait and personalized recommendations for an individual’s health, based on integrated analysis of longitudinal blood, genetics and gut microbiome profiles. The company offers health tests to generate comprehensive, personalized molecular portraits for its customers.
THORNE HEALTHTECH INC
620 Omni Industrial Blvd.
Summerville SOUTH CAROLINA US
CEO: Paul F. Jacobson
Employees: 544
Company Website: https://investors.thornehealthtech.com/overview/
Phone: 18435010286.0
The current stock price of THRN is 10.19 USD. The price decreased by -0.1% in the last trading session.
The exchange symbol of THORNE HEALTHTECH INC is THRN and it is listed on the Nasdaq exchange.
THRN stock is listed on the Nasdaq exchange.
10 analysts have analysed THRN and the average price target is 8.61 USD. This implies a price decrease of -15.52% is expected in the next year compared to the current price of 10.19. Check the THORNE HEALTHTECH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
THORNE HEALTHTECH INC (THRN) has a market capitalization of 550.67M USD. This makes THRN a Small Cap stock.
THORNE HEALTHTECH INC (THRN) currently has 544 employees.
THORNE HEALTHTECH INC (THRN) has a support level at 10.19 and a resistance level at 10.2. Check the full technical report for a detailed analysis of THRN support and resistance levels.
The Revenue of THORNE HEALTHTECH INC (THRN) is expected to grow by 23.62% in the next year. Check the estimates tab for more information on the THRN EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
THRN does not pay a dividend.
THORNE HEALTHTECH INC (THRN) will report earnings on 2023-11-09, after the market close.
The PE ratio for THORNE HEALTHTECH INC (THRN) is 26.82. This is based on the reported non-GAAP earnings per share of 0.38 and the current share price of 10.19 USD. Check the full fundamental report for a full analysis of the valuation metrics for THRN.
ChartMill assigns a technical rating of 8 / 10 to THRN. When comparing the yearly performance of all stocks, THRN is one of the better performing stocks in the market, outperforming 99.36% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to THRN. THRN has only an average score on both its financial health and profitability.
Over the last trailing twelve months THRN reported a non-GAAP Earnings per Share(EPS) of 0.38. The EPS increased by 660% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 7.94% | ||
ROA | 7.2% | ||
ROE | 13.21% | ||
Debt/Equity | 0.17 |
ChartMill assigns a Buy % Consensus number of 80% to THRN. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of 14.31% and a revenue growth 23.62% for THRN